What are the latest FDA guidelines regarding the long term use of hormone replacement therapy for women going through late onset menopause?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the latest FDA guidelines regarding the long term use of hormone replacement therapy for women going through late onset menopause?
3 real searches · 1 real-search pass
FDA latest 2026 menopausal hormone therapy labeling boxed warning long-term use women age 60 10 years since menopauseGoogle ↗
OBSERVED
FDA menopause hormone therapy guidance long term use older women 2026 official FDAGoogle ↗
OBSERVED
The Menopause Society hormone therapy position statement age 60 10 years since menopause duration long term 2025Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
FDA latest 2026 menopausal hormone therapy labeling boxed warning long-term use women age 60 10 years since menopause Google ↗
FDA menopause hormone therapy guidance long term use older women 2026 official FDA Google ↗
The Menopause Society hormone therapy position statement age 60 10 years since menopause duration long term 2025 Google ↗
- FDA Approves Labeling Changes to Menopausal Hormone Therapy Products · fda.gov
- FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies · fda.gov
- Menopausal Hormone Therapies with Updated Prescribing Information · fda.gov
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- Initiation of Hormone Therapy After Age 65 Remains Risky but Still Works for Some Women · menopause.org
- Hormone therapy safety · womenshealth.gov
- Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms · fda.gov
- Full article: Menopause and MHT in 2024: addressing the key controversies · doi.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA latest 2026 menopausal hormone therapy labeling boxed warning long-term use women age 60 10 years since menopause OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA menopause hormone therapy guidance long term use older women 2026 official FDA OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
The Menopause Society hormone therapy position statement age 60 10 years since menopause duration long term 2025 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |